top of page
  • Facebook
  • White Twitter Icon
  • Soundcloud
  • White Instagram Icon
  • LinkedIn
  • TikTok

Cannabis for Pain: Cannabis for Pain Patients in Hemodialysis

Updated: Apr 24, 2023

Welcome to homework assignment CPS 1.5 in the Cannabis for Pain seminar from Higher Learning LV. This seminar provides a review of recently published peer-reviewed scientific research on the topic of the potential medicinal efficacy of cannabis for pain. This assignment in particular focuses on a 2023 study conducted in Tel-Aviv, Israel that considered the potential medicinal efficacy of cannabis for pain patients undergoing hemodialysis .

When you complete this homework assignment, simply click the link at the bottom of the article to return to the master page for this seminar.

A 2023 study entitled "Medical Cannabis for Pain Management in Patients Undergoing Chronic Hemodialysis: Randomized, Double-blind, Cross-over Feasibility Study" that was published in the Clinical Kidney Journal explored the safety of sublingual oil-based medical cannabis "for pain management in patients undergoing hemodialysis."

Want to read more?

Subscribe to curtarobbins.wixsite.com to keep reading this exclusive post.

Higher Learning LV

There are many ways to learn from us, including 👇🏽

Teaching the Commerce + Chemistry of Cannabis™

Did You Know?

The cannabis genome produces 100+ cannabinoids, 150+ terpenes, and 20 flavonoids.

These phytomolecules interact with the human endocannabinoid system (ECS) to produce wellness.

But it gets complex. Biphasic response curves, biosynthetic pathways, and acidic precursors all commingle. Subscribe to learn how. 

Copyright © 2023 Higher Learning LV. All Rights Reserved. Unauthorized reuse strictly prohibited.

bottom of page